世界のP2X7受容体拮抗薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global P2X7 Receptor Antagonists Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4643
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、P2X7受容体拮抗薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（GSK1482160、AZD9056、EVT 401、JNJ 55308942＆JNJ 54175446、AKP-23494954/RQ-00466479、その他）、用途別市場規模（炎症性疾患、中枢神経系疾患、免疫系障害）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・P2X7受容体拮抗薬の市場動向
・企業の競争状況、市場シェア
・P2X7受容体拮抗薬の種類別市場規模と予測2016-2027（GSK1482160、AZD9056、EVT 401、JNJ 55308942＆JNJ 54175446、AKP-23494954/RQ-00466479、その他）
・P2X7受容体拮抗薬の用途別市場規模と予測2016-2027（炎症性疾患、中枢神経系疾患、免疫系障害）
・P2X7受容体拮抗薬の北米市場規模2016-2027（アメリカ、カナダ）
・P2X7受容体拮抗薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・P2X7受容体拮抗薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・P2X7受容体拮抗薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・P2X7受容体拮抗薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、AstraZeneca、Janssen、RaQualia Pharma、Evotec、Asahi Kasei Pharma、Pfizer）
・結論

P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer’s disease, spinal cord injury and neuropathic pain.

Market Analysis and Insights: Global P2X7 Receptor Antagonists Market
The global P2X7 Receptor Antagonists market size is projected to reach US$ 112.7 million by 2027, from US$ 54 million in 2020, at a CAGR of 10.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global P2X7 Receptor Antagonists market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global P2X7 Receptor Antagonists market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global P2X7 Receptor Antagonists market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global P2X7 Receptor Antagonists market.

Global P2X7 Receptor Antagonists Scope and Market Size
P2X7 Receptor Antagonists market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global P2X7 Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others

Segment by Application
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global P2X7 Receptor Antagonists Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 GSK1482160
1.2.3 AZD9056
1.2.4 EVT 401
1.2.5 JNJ 55308942 & JNJ 54175446
1.2.6 AKP-23494954/RQ-00466479
1.2.7 Others
1.3 Market by Application
1.3.1 Global P2X7 Receptor Antagonists Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Inflammatory Diseases
1.3.3 Central Nervous System Diseases
1.3.4 Immune System Disorders
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global P2X7 Receptor Antagonists Market Perspective (2016-2027)
2.2 P2X7 Receptor Antagonists Growth Trends by Regions
2.2.1 P2X7 Receptor Antagonists Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 P2X7 Receptor Antagonists Historic Market Share by Regions (2016-2021)
2.2.3 P2X7 Receptor Antagonists Forecasted Market Size by Regions (2022-2027)
2.3 P2X7 Receptor Antagonists Industry Dynamic
2.3.1 P2X7 Receptor Antagonists Market Trends
2.3.2 P2X7 Receptor Antagonists Market Drivers
2.3.3 P2X7 Receptor Antagonists Market Challenges
2.3.4 P2X7 Receptor Antagonists Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top P2X7 Receptor Antagonists Players by Revenue
3.1.1 Global Top P2X7 Receptor Antagonists Players by Revenue (2016-2021)
3.1.2 Global P2X7 Receptor Antagonists Revenue Market Share by Players (2016-2021)
3.2 Global P2X7 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by P2X7 Receptor Antagonists Revenue
3.4 Global P2X7 Receptor Antagonists Market Concentration Ratio
3.4.1 Global P2X7 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by P2X7 Receptor Antagonists Revenue in 2020
3.5 P2X7 Receptor Antagonists Key Players Head office and Area Served
3.6 Key Players P2X7 Receptor Antagonists Product Solution and Service
3.7 Date of Enter into P2X7 Receptor Antagonists Market
3.8 Mergers & Acquisitions, Expansion Plans

4 P2X7 Receptor Antagonists Breakdown Data by Type
4.1 Global P2X7 Receptor Antagonists Historic Market Size by Type (2016-2021)
4.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2022-2027)

5 P2X7 Receptor Antagonists Breakdown Data by Application
5.1 Global P2X7 Receptor Antagonists Historic Market Size by Application (2016-2021)
5.2 Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America P2X7 Receptor Antagonists Market Size (2016-2027)
6.2 North America P2X7 Receptor Antagonists Market Size by Type
6.2.1 North America P2X7 Receptor Antagonists Market Size by Type (2016-2021)
6.2.2 North America P2X7 Receptor Antagonists Market Size by Type (2022-2027)
6.2.3 North America P2X7 Receptor Antagonists Market Size by Type (2016-2027)
6.3 North America P2X7 Receptor Antagonists Market Size by Application
6.3.1 North America P2X7 Receptor Antagonists Market Size by Application (2016-2021)
6.3.2 North America P2X7 Receptor Antagonists Market Size by Application (2022-2027)
6.3.3 North America P2X7 Receptor Antagonists Market Size by Application (2016-2027)
6.4 North America P2X7 Receptor Antagonists Market Size by Country
6.4.1 North America P2X7 Receptor Antagonists Market Size by Country (2016-2021)
6.4.2 North America P2X7 Receptor Antagonists Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe P2X7 Receptor Antagonists Market Size (2016-2027)
7.2 Europe P2X7 Receptor Antagonists Market Size by Type
7.2.1 Europe P2X7 Receptor Antagonists Market Size by Type (2016-2021)
7.2.2 Europe P2X7 Receptor Antagonists Market Size by Type (2022-2027)
7.2.3 Europe P2X7 Receptor Antagonists Market Size by Type (2016-2027)
7.3 Europe P2X7 Receptor Antagonists Market Size by Application
7.3.1 Europe P2X7 Receptor Antagonists Market Size by Application (2016-2021)
7.3.2 Europe P2X7 Receptor Antagonists Market Size by Application (2022-2027)
7.3.3 Europe P2X7 Receptor Antagonists Market Size by Application (2016-2027)
7.4 Europe P2X7 Receptor Antagonists Market Size by Country
7.4.1 Europe P2X7 Receptor Antagonists Market Size by Country (2016-2021)
7.4.2 Europe P2X7 Receptor Antagonists Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific P2X7 Receptor Antagonists Market Size (2016-2027)
8.2 Asia-Pacific P2X7 Receptor Antagonists Market Size by Type
8.2.1 Asia-Pacific P2X7 Receptor Antagonists Market Size by Type (2016-2021)
8.2.2 Asia-Pacific P2X7 Receptor Antagonists Market Size by Type (2022-2027)
8.2.3 Asia-Pacific P2X7 Receptor Antagonists Market Size by Type (2016-2027)
8.3 Asia-Pacific P2X7 Receptor Antagonists Market Size by Application
8.3.1 Asia-Pacific P2X7 Receptor Antagonists Market Size by Application (2016-2021)
8.3.2 Asia-Pacific P2X7 Receptor Antagonists Market Size by Application (2022-2027)
8.3.3 Asia-Pacific P2X7 Receptor Antagonists Market Size by Application (2016-2027)
8.4 Asia-Pacific P2X7 Receptor Antagonists Market Size by Region
8.4.1 Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2016-2021)
8.4.2 Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America P2X7 Receptor Antagonists Market Size (2016-2027)
9.2 Latin America P2X7 Receptor Antagonists Market Size by Type
9.2.1 Latin America P2X7 Receptor Antagonists Market Size by Type (2016-2021)
9.2.2 Latin America P2X7 Receptor Antagonists Market Size by Type (2022-2027)
9.2.3 Latin America P2X7 Receptor Antagonists Market Size by Type (2016-2027)
9.3 Latin America P2X7 Receptor Antagonists Market Size by Application
9.3.1 Latin America P2X7 Receptor Antagonists Market Size by Application (2016-2021)
9.3.2 Latin America P2X7 Receptor Antagonists Market Size by Application (2022-2027)
9.3.3 Latin America P2X7 Receptor Antagonists Market Size by Application (2016-2027)
9.4 Latin America P2X7 Receptor Antagonists Market Size by Country
9.4.1 Latin America P2X7 Receptor Antagonists Market Size by Country (2016-2021)
9.4.2 Latin America P2X7 Receptor Antagonists Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa P2X7 Receptor Antagonists Market Size (2016-2027)
10.2 Middle East & Africa P2X7 Receptor Antagonists Market Size by Type
10.2.1 Middle East & Africa P2X7 Receptor Antagonists Market Size by Type (2016-2021)
10.2.2 Middle East & Africa P2X7 Receptor Antagonists Market Size by Type (2022-2027)
10.2.3 Middle East & Africa P2X7 Receptor Antagonists Market Size by Type (2016-2027)
10.3 Middle East & Africa P2X7 Receptor Antagonists Market Size by Application
10.3.1 Middle East & Africa P2X7 Receptor Antagonists Market Size by Application (2016-2021)
10.3.2 Middle East & Africa P2X7 Receptor Antagonists Market Size by Application (2022-2027)
10.3.3 Middle East & Africa P2X7 Receptor Antagonists Market Size by Application (2016-2027)
10.4 Middle East & Africa P2X7 Receptor Antagonists Market Size by Country
10.4.1 Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2016-2021)
10.4.2 Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Introduction
11.1.4 GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca P2X7 Receptor Antagonists Introduction
11.2.4 AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Janssen
11.3.1 Janssen Company Details
11.3.2 Janssen Business Overview
11.3.3 Janssen P2X7 Receptor Antagonists Introduction
11.3.4 Janssen Revenue in P2X7 Receptor Antagonists Business (2016-2021)
11.3.5 Janssen Recent Development
11.4 RaQualia Pharma
11.4.1 RaQualia Pharma Company Details
11.4.2 RaQualia Pharma Business Overview
11.4.3 RaQualia Pharma P2X7 Receptor Antagonists Introduction
11.4.4 RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2016-2021)
11.4.5 RaQualia Pharma Recent Development
11.5 Evotec
11.5.1 Evotec Company Details
11.5.2 Evotec Business Overview
11.5.3 Evotec P2X7 Receptor Antagonists Introduction
11.5.4 Evotec Revenue in P2X7 Receptor Antagonists Business (2016-2021)
11.5.5 Evotec Recent Development
11.6 Asahi Kasei Pharma
11.6.1 Asahi Kasei Pharma Company Details
11.6.2 Asahi Kasei Pharma Business Overview
11.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Introduction
11.6.4 Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2016-2021)
11.6.5 Asahi Kasei Pharma Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer P2X7 Receptor Antagonists Introduction
11.7.4 Pfizer Revenue in P2X7 Receptor Antagonists Business (2016-2021)
11.7.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global P2X7 Receptor Antagonists Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of GSK1482160
Table 3. Key Players of AZD9056
Table 4. Key Players of EVT 401
Table 5. Key Players of JNJ 55308942 & JNJ 54175446
Table 6. Key Players of AKP-23494954/RQ-00466479
Table 7. Key Players of Others
Table 8. Global P2X7 Receptor Antagonists Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global P2X7 Receptor Antagonists Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global P2X7 Receptor Antagonists Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global P2X7 Receptor Antagonists Market Share by Regions (2016-2021)
Table 12. Global P2X7 Receptor Antagonists Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global P2X7 Receptor Antagonists Market Share by Regions (2022-2027)
Table 14. P2X7 Receptor Antagonists Market Trends
Table 15. P2X7 Receptor Antagonists Market Drivers
Table 16. P2X7 Receptor Antagonists Market Challenges
Table 17. P2X7 Receptor Antagonists Market Restraints
Table 18. Global P2X7 Receptor Antagonists Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global P2X7 Receptor Antagonists Market Share by Players (2016-2021)
Table 20. Global Top P2X7 Receptor Antagonists Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in P2X7 Receptor Antagonists as of 2020)
Table 21. Ranking of Global Top P2X7 Receptor Antagonists Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by P2X7 Receptor Antagonists Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players P2X7 Receptor Antagonists Product Solution and Service
Table 25. Date of Enter into P2X7 Receptor Antagonists Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global P2X7 Receptor Antagonists Market Size by Type (2016-2021) (US$ Million)
Table 28. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2016-2021)
Table 29. Global P2X7 Receptor Antagonists Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global P2X7 Receptor Antagonists Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global P2X7 Receptor Antagonists Revenue Market Share by Application (2016-2021)
Table 33. Global P2X7 Receptor Antagonists Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global P2X7 Receptor Antagonists Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America P2X7 Receptor Antagonists Market Size by Type (2016-2021) (US$ Million)
Table 36. North America P2X7 Receptor Antagonists Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America P2X7 Receptor Antagonists Market Size by Application (2016-2021) (US$ Million)
Table 38. North America P2X7 Receptor Antagonists Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America P2X7 Receptor Antagonists Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America P2X7 Receptor Antagonists Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe P2X7 Receptor Antagonists Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe P2X7 Receptor Antagonists Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe P2X7 Receptor Antagonists Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe P2X7 Receptor Antagonists Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe P2X7 Receptor Antagonists Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe P2X7 Receptor Antagonists Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific P2X7 Receptor Antagonists Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific P2X7 Receptor Antagonists Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific P2X7 Receptor Antagonists Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific P2X7 Receptor Antagonists Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific P2X7 Receptor Antagonists Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America P2X7 Receptor Antagonists Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America P2X7 Receptor Antagonists Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America P2X7 Receptor Antagonists Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America P2X7 Receptor Antagonists Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America P2X7 Receptor Antagonists Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America P2X7 Receptor Antagonists Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa P2X7 Receptor Antagonists Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa P2X7 Receptor Antagonists Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa P2X7 Receptor Antagonists Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa P2X7 Receptor Antagonists Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa P2X7 Receptor Antagonists Market Size by Country (2022-2027) & (US$ Million)
Table 65. GlaxoSmithKline Company Details
Table 66. GlaxoSmithKline Business Overview
Table 67. GlaxoSmithKline P2X7 Receptor Antagonists Product
Table 68. GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2016-2021) & (US$ Million)
Table 69. GlaxoSmithKline Recent Development
Table 70. AstraZeneca Company Details
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca P2X7 Receptor Antagonists Product
Table 73. AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2016-2021) & (US$ Million)
Table 74. AstraZeneca Recent Development
Table 75. Janssen Company Details
Table 76. Janssen Business Overview
Table 77. Janssen P2X7 Receptor Antagonists Product
Table 78. Janssen Revenue in P2X7 Receptor Antagonists Business (2016-2021) & (US$ Million)
Table 79. Janssen Recent Development
Table 80. RaQualia Pharma Company Details
Table 81. RaQualia Pharma Business Overview
Table 82. RaQualia Pharma P2X7 Receptor Antagonists Product
Table 83. RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2016-2021) & (US$ Million)
Table 84. RaQualia Pharma Recent Development
Table 85. Evotec Company Details
Table 86. Evotec Business Overview
Table 87. Evotec P2X7 Receptor Antagonists Product
Table 88. Evotec Revenue in P2X7 Receptor Antagonists Business (2016-2021) & (US$ Million)
Table 89. Evotec Recent Development
Table 90. Asahi Kasei Pharma Company Details
Table 91. Asahi Kasei Pharma Business Overview
Table 92. Asahi Kasei Pharma P2X7 Receptor Antagonists Product
Table 93. Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2016-2021) & (US$ Million)
Table 94. Asahi Kasei Pharma Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer P2X7 Receptor Antagonists Product
Table 98. Pfizer Revenue in P2X7 Receptor Antagonists Business (2016-2021) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global P2X7 Receptor Antagonists Market Share by Type: 2020 VS 2027
Figure 2. GSK1482160 Features
Figure 3. AZD9056 Features
Figure 4. EVT 401 Features
Figure 5. JNJ 55308942 & JNJ 54175446 Features
Figure 6. AKP-23494954/RQ-00466479 Features
Figure 7. Others Features
Figure 8. Global P2X7 Receptor Antagonists Market Share by Application: 2020 VS 2027
Figure 9. Inflammatory Diseases Case Studies
Figure 10. Central Nervous System Diseases Case Studies
Figure 11. Immune System Disorders Case Studies
Figure 12. P2X7 Receptor Antagonists Report Years Considered
Figure 13. Global P2X7 Receptor Antagonists Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global P2X7 Receptor Antagonists Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global P2X7 Receptor Antagonists Market Share by Regions: 2020 VS 2027
Figure 16. Global P2X7 Receptor Antagonists Market Share by Regions (2022-2027)
Figure 17. Global P2X7 Receptor Antagonists Market Share by Players in 2020
Figure 18. Global Top P2X7 Receptor Antagonists Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in P2X7 Receptor Antagonists as of 2020
Figure 19. The Top 10 and 5 Players Market Share by P2X7 Receptor Antagonists Revenue in 2020
Figure 20. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2016-2021)
Figure 21. Global P2X7 Receptor Antagonists Revenue Market Share by Type (2022-2027)
Figure 22. North America P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America P2X7 Receptor Antagonists Market Share by Type (2016-2027)
Figure 24. North America P2X7 Receptor Antagonists Market Share by Application (2016-2027)
Figure 25. North America P2X7 Receptor Antagonists Market Share by Country (2016-2027)
Figure 26. United States P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe P2X7 Receptor Antagonists Market Share by Type (2016-2027)
Figure 30. Europe P2X7 Receptor Antagonists Market Share by Application (2016-2027)
Figure 31. Europe P2X7 Receptor Antagonists Market Share by Country (2016-2027)
Figure 32. Germany P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific P2X7 Receptor Antagonists Market Share by Type (2016-2027)
Figure 40. Asia-Pacific P2X7 Receptor Antagonists Market Share by Application (2016-2027)
Figure 41. Asia-Pacific P2X7 Receptor Antagonists Market Share by Region (2016-2027)
Figure 42. China P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America P2X7 Receptor Antagonists Market Share by Type (2016-2027)
Figure 50. Latin America P2X7 Receptor Antagonists Market Share by Application (2016-2027)
Figure 51. Latin America P2X7 Receptor Antagonists Market Share by Country (2016-2027)
Figure 52. Mexico P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa P2X7 Receptor Antagonists Market Share by Type (2016-2027)
Figure 56. Middle East & Africa P2X7 Receptor Antagonists Market Share by Application (2016-2027)
Figure 57. Middle East & Africa P2X7 Receptor Antagonists Market Share by Country (2016-2027)
Figure 58. Turkey P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE P2X7 Receptor Antagonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. GlaxoSmithKline Revenue Growth Rate in P2X7 Receptor Antagonists Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in P2X7 Receptor Antagonists Business (2016-2021)
Figure 63. Janssen Revenue Growth Rate in P2X7 Receptor Antagonists Business (2016-2021)
Figure 64. RaQualia Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2016-2021)
Figure 65. Evotec Revenue Growth Rate in P2X7 Receptor Antagonists Business (2016-2021)
Figure 66. Asahi Kasei Pharma Revenue Growth Rate in P2X7 Receptor Antagonists Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in P2X7 Receptor Antagonists Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のCXCR4拮抗薬市場規模・現状・予測（2021年-2027年）

Global CXCR4 Antagonists Market Size, Status and Forecast 2021-2027
QFJ1-5686 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、CXCR4拮抗薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BL-8040、GMI-1359、プレリキサフォル（AMD3100）、バリキサフォルチド（POL6326）、USL311、その他）、用途...

世界のインターロイキン12受容体市場規模・現状・予測（2021年-2027年）

Global Interleukin 12 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5806 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、インターロイキン12受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エドデキンアルファSR、M-9241、LY-3232094、NMIL-121、その他）、用途別市場規模（入院患者、外来患者）、...

世界のC-X-Cケモカイン受容体タイプ1市場規模・現状・予測（2021年-2027年）

Global C-X-C Chemokine Receptor Type 1 Market Size, Status and Forecast 2021-2027
QFJ1-5683 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ1の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DF-2755A、PAC-G31P、レパリキシン、SX-576、その他）、用途別市場規模（炎症、肺がん、黒色腫、術後痛...

世界のエフリンB型受容体4市場規模・現状・予測（2021年-2027年）

Global Ephrin Type B Receptor 4 Market Size, Status and Forecast 2021-2027
QFJ1-5725 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、エフリンB型受容体4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VDAU-11、Vas-01、トシレートテセバチニブ、その他）、用途別市場規模（固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他）、...

世界のN-ホルミルペプチド受容体2市場規模・現状・予測（2021年-2027年）

Global N-Formyl Peptide Receptor 2 Market Size, Status and Forecast 2021-2027
QFJ1-5886 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、N-ホルミルペプチド受容体2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TR-8、NCP-70X、ヒューマニン、その他）、用途別市場規模（炎症、2型糖尿病、アレルギー、脳虚血、転移性がん、その他）...

世界のブラジキニンB1受容体市場規模・現状・予測（2021年-2027年）

Global Bradykinin B1 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5635 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、ブラジキニンB1受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BI-113823、その他）、用途別市場規模（診療所、病院、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のα2Cアドレナリン受容体市場規模・現状・予測（2021年-2027年）

Global Alpha 2C Adrenergic Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5572 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、α2Cアドレナリン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラクリペップ、JNJ-4789、SKL-PSY、その他）、用途別市場規模（双極性障害、ドライアイ、大うつ病、その他）、主要地域別...

世界のGLP-1受容体アゴニスト市場規模・現状・予測（2021年-2027年）

Global GLP-1 Receptor Agonists Market Size, Status and Forecast 2021-2027
QFJ1-4259 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、GLP-1受容体アゴニストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場...

世界のプロスタグランジンE2受容体EP2サブタイプ市場規模・現状・予測（2021年-2027年）

Global Prostaglandin E2 Receptor EP2 Subtype Market Size, Status and Forecast 2021-2027
QFJ1-5966 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、プロスタグランジンE2受容体EP2サブタイプの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TG-4155、SAR-366234、ONO-8055、トレプロスチニル、その他）、用途別市場規模（クリニッ...

世界のトロンボポエチン受容体市場規模・現状・予測（2021年-2027年）

Global Thrombopoietin Receptor Market Size, Status and Forecast 2021-2027
QFJ1-6039 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、トロンボポエチン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エルトロンボパグオラミン、GSK-2285921、ロミプロスティム、STST-4、その他）、用途別市場規模（クリニック、病院、その...

世界の中枢神経系疾患治療薬市場規模・現状・予測（2021年-2027年） A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous system Market Analysis and Insights: Global Drugs for Central Nervous System Diseases Market The global Drugs for Central Nervous System Diseases market size is projected to reac…
中枢神経系疾患薬品のグローバル市場：規模・現状・予測2019-2025 A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous systemIn 2018, the global Drugs for Central Nervous System Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of x…
中枢神経系疾患薬品のグローバル市場：規模・現状・予測2019-2025 A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous systemIn 2018, the global Drugs for Central Nervous System Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of x…
世界のCXCR4拮抗薬市場規模・現状・予測（2021年-2027年） CXCR4 antagonists are small-molecule which block the CXCR4 receptors and prevent their activation. Blocking the receptors stop the receptors' ligand, CXCL12, from binding which prevent downstream effects. CXCR4 antagonists are especially important for hindering cancer progression because one of the …
世界のC-Cケモカイン受容体タイプ4市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global C-C Chemokine Receptor Type 4 Market The global C-C Chemokine Receptor Type 4 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…